JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB38017

Anti-SF2 antibody

4

(6 Reviews)

|

(36 Publications)

Rabbit Polyclonal SF2 antibody. Suitable for IP, WB, ICC/IF, IHC-P and reacts with Human samples. Cited in 36 publications.

View Alternative Names

ASF, SF2, SF2P33, SFRS1, OK/SW-cl.3, SRSF1, Serine/arginine-rich splicing factor 1, Alternative-splicing factor 1, ASF-1

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SF2 antibody (AB38017)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SF2 antibody (AB38017)

IHC image of SF2 staining in Human normal spleen formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab38017, 5μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Immunocytochemistry/ Immunofluorescence - Anti-SF2 antibody (AB38017)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-SF2 antibody (AB38017)

ICC/IF image of ab38017 stained human HeLa cells. The cells were PFA fixed (10 min), permabilised in TBS-T (20 min) and incubated with the antibody (ab38017, 5μg/ml) for 1h at room temperature. 1%BSA / 10% normal serum / 0.3M glycine was used to quench autofluorescence and block non-specific protein-protein interactions. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red). DAPI was used to stain the cell nuclei (blue).

Western blot - Anti-SF2 antibody (AB38017)
  • WB

Ap

Western blot - Anti-SF2 antibody (AB38017)

SF2 is extensively phosphorylated on serine residues in the RS domain (SwissProt).

ab38017 is targeted against all isoforms of the SF2 protein.

All lanes:

Western blot - Anti-SF2 antibody (ab38017) at 1 µg/mL

Lane 1:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Lane 2:

Western blot - Jurkat whole cell lysate (<a href='/en-us/products/cell-lysates/jurkat-whole-cell-lysate-ab7899'>ab7899</a>) at 10 µg

Lane 3:

Western blot - A-431 whole cell lysate (<a href='/en-us/products/cell-lysates/a-431-whole-cell-lysate-ab7909'>ab7909</a>) at 10 µg

Lane 4:

Western blot - HEK-293 whole cell lysate (<a href='/en-us/products/cell-lysates/hek-293-whole-cell-lysate-ab7902'>ab7902</a>) at 10 µg

Lane 5:

Hep G2 whole cell lysate (<a href='/en-us/products/unavailable/hep-g2-whole-cell-lysate-ab7900'>ab7900</a>) at 10 µg

Lane 6:

MCF-7 (Human breast adenocarcinoma cell line) Whole Cell Lysate at 10 µg

Lane 7:

SHSY-5Y (Human neuroblastoma cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/10000 dilution

Predicted band size: 28 kDa

Observed band size: 34 kDa

false

Western blot - Anti-SF2 antibody (AB38017)
  • WB

AbReview10498****

Western blot - Anti-SF2 antibody (AB38017)

All lanes:

Western blot - Anti-SF2 antibody (ab38017) at 1 µg/mL

Lane 1:

HeLa whole cell lysate at 20 µg

Lane 2:

293T whole cell lysate at 20 µg

Secondary

All lanes:

Alexa Fluor® conjugated goat anti-rabbit antibody at 1/10000 dilution

Predicted band size: 28 kDa

Observed band size: 34 kDa,50 kDa

true

Exposure time: 10s

This image is courtesy of an anonymous Abreview

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF, IHC-P, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

From Jan 2024, QC testing of replenishment batches of this polyclonal changed. All tested and expected application and reactive species combinations are still covered by our Abcam product promise. However, we no longer test all applications. For more information on a specific batch, please contact our Scientific Support who will be happy to help. You may also be interested in our alternative recombinant antibody, ab129108.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Chicken": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Pig": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Zebrafish": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SF2 also known as Splicing Factor 2 or Alternative Splicing Factor 1 (ASF1) is a prototypical member of the SR protein family involved in mRNA splicing. It is approximately 33 kDa in mass. SF2 is expressed ubiquitously in the nucleus of eukaryotic cells where it plays a central role in the regulation of constitutive and alternative splicing processes.
Biological function summary

SF2 acts as an important regulator of gene expression by facilitating the splicing of pre-mRNA participating in spliceosome assembly. It interacts with other splicing factors and RNA to form spliceosomal complexes essential for splicing fidelity and efficiency. The precise modulation of splicing by SF2 allows for the generation of diverse protein isoforms from a single gene contributing to protein diversity within the cell.

Pathways

SF2 integrates into the RNA splicing pathway and is critical for splice site selection. It interacts with proteins such as U1 snRNP and U2AF65 influencing their binding to pre-mRNA. SF2 also plays roles in other key pathways like mRNA transport and translation thereby linking the splicing machinery with nuclear export and protein synthesis processes.

Abnormalities in SF2 levels or functions have been linked to various cancers and spinal muscular atrophy (SMA). Cancer cells often show altered SF2 expression leading to splicing anomalies that promote tumorigenesis. Additionally SF2's interaction with proteins like hnRNP A1 influences disease mechanisms as splicing factor dysregulation can disrupt normal cellular processes and facilitate the progression of disorders such as SMA.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Plays a role in preventing exon skipping, ensuring the accuracy of splicing and regulating alternative splicing. Interacts with other spliceosomal components, via the RS domains, to form a bridge between the 5'- and 3'-splice site binding components, U1 snRNP and U2AF. Can stimulate binding of U1 snRNP to a 5'-splice site-containing pre-mRNA. Binds to purine-rich RNA sequences, either the octamer, 5'-RGAAGAAC-3' (r=A or G) or the decamers, AGGACAGAGC/AGGACGAAGC. Binds preferentially to the 5'-CGAGGCG-3' motif in vitro. Three copies of the octamer constitute a powerful splicing enhancer in vitro, the ASF/SF2 splicing enhancer (ASE) which can specifically activate ASE-dependent splicing. Isoform ASF-2 and isoform ASF-3 act as splicing repressors. May function as export adapter involved in mRNA nuclear export through the TAP/NXF1 pathway.
See full target information SRSF1

Publications (36)

Recent publications for all applications. Explore the full list and refine your search

Hereditas 162:110 PubMed40537877

2025

Mechanism of LINC00958 in ferroptosis of breast cancer through the SRSF1/GPX4 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Shan Wang,Xinlu Liu,Xiaoli Hou,Wei Sun,Jiajie Chen,Yasen Cao,Hong Cheng

Cellular and molecular life sciences : CMLS 81:307 PubMed39048814

2024

CircARAP2 controls sMICA-induced NK cell desensitization by erasing CTCF/PRC2-induced suppression in early endosome marker RAB5A.

Applications

Unspecified application

Species

Unspecified reactive species

Feifei Guo,Nawen Du,Xue Wen,Zhaozhi Li,Yantong Guo,Lei Zhou,Andrew R Hoffman,Lingyu Li,Ji-Fan Hu,Jiuwei Cui

iScience 27:109861 PubMed38799570

2024

Circ_0007432 promotes non-small cell lung cancer progression and macrophage M2 polarization through SRSF1/KLF12 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Shanshan Mao,Dongyu Wu,Xiaozhen Cheng,Jinsheng Wu

Cell insight 3:100170 PubMed38590928

2024

LUC7L3 is a downstream factor of SRSF1 and prevents genomic instability.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaqing Zhang,Jing Guo,Xin Shi,Xin Zhou,Qiang Chen

Cells 12: PubMed36672150

2023

The Fibrotic Effects of LINC00663 in Human Hepatic Stellate LX-2 Cells and in Bile Duct-Ligated Cholestasis Mice Are Mediated through the Splicing Factor 2-Fibronectin.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Chu,Linan Bao,Yun Teng,Bo Yuan,Lijie Ma,Ying Liu,Hui Kang

Oxidative medicine and cellular longevity 2022:8645830 PubMed36062189

2022

Circ_000829 Plays an Anticancer Role in Renal Cell Carcinoma by Suppressing SRSF1-Mediated Alternative Splicing of SLC39A14.

Applications

Unspecified application

Species

Unspecified reactive species

Jia-Fu Feng,Wen-Yu Yang,Yao-Dong Wang,Gang Xie,Bei Xu,Chun-Mei Dai,Bin Zhang,Xiao-Han Li,Jun Wang,Yu-Wei Yang

Nucleic acids research 50:5493-5512 PubMed35474482

2022

Exonic splicing code and protein binding sites for calcium.

Applications

Unspecified application

Species

Unspecified reactive species

Reuben J Pengelly,Dara Bakhtiar,Ivana Borovská,Jana Královičová,Igor Vořechovský

Developmental cell 57:624-637.e4 PubMed35202586

2022

SRSF1 governs progenitor-specific alternative splicing to maintain adult epithelial tissue homeostasis and renewal.

Applications

Unspecified application

Species

Unspecified reactive species

Tingsheng Yu,Oscar Cazares,Alison D Tang,Hyun-Yi Kim,Tomas Wald,Adya Verma,Qi Liu,Mary Helen Barcellos-Hoff,Stephen N Floor,Han-Sung Jung,Angela N Brooks,Ophir D Klein

The Journal of biological chemistry 297:101306 PubMed34673031

2021

Phosphorylation regulates arginine-rich RNA-binding protein solubility and oligomerization.

Applications

Unspecified application

Species

Unspecified reactive species

Sean R Kundinger,Eric B Dammer,Luming Yin,Cheyenne Hurst,Sarah Shapley,Lingyan Ping,Sohail Khoshnevis,Homa Ghalei,Duc M Duong,Nicholas T Seyfried

Journal of translational medicine 19:210 PubMed34001131

2021

CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Qianmei Fu,Xiaohong Tan,Huaming Tang,Jijiang Liu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com